Synthesis and Evaluation of Cytotoxic Activity of 2-Aryl-2-(3-Indolyl)Propionic Acid Derivatives
Authors:
- Alexander V. AksenovAlexander V. Aksenov
- Nicolai A. AksenovNANicolai A. Aksenov
- Nikolai A. ArutiunovNANikolai A. Arutiunov
- Dmitrii A. AksenovDADmitrii A. Aksenov
- Anna M. ZatsepilinaAZAnna M. Zatsepilina
- Daria I. MurashkinaDMDaria I. Murashkina
- Maksim O. ShcheglovMSMaksim O. Shcheglov
- Sergei N. OvcharovSOSergei N. Ovcharov
Open Access
Abstract
2-Aryl-2-(3-indolyl)acetohydroxamic acids have emerged as promising antitumor agents; however, their poor pharmacokinetic profile remains a significant drawback. To address this limitation, we have synthesized a homolog of such acids—specifically 2-aryl-2-(3-indolyl)propionic acid (IC50 > 100 mM (U87)), along with several other derivatives: ethyl ester (IC50 > 100 mM (U87)), hydroxamate (IC50 21.2 ± 1.0 mM (U87)) and hydrazide (IC50 > 100 mM (U87)). The cytotoxicity of these compounds against glioblastoma cell lines was evaluated and compared to that of the parent acetohydroxamic acid derivatives.Keywords
All Related Versions
Funding Information
- Ministry of Science and Higher Education of the Russian Federation (#FSRN-2023-0005)
This publication has 12 references indexed in Scilit:
- Indole Derived Anticancer AgentsChemistrySelect, 2022
- Structure modification and biological evaluation of indole-chalcone derivatives as anti-tumor agents through dual targeting tubulin and TrxREuropean Journal of Medicinal Chemistry, 2022
- Methylation of 2-Aryl-2-(3-indolyl)acetohydroxamic Acids and Evaluation of Cytotoxic Activity of the ProductsMolbank, 2021
- Polyphenols as Antitumor Agents Targeting Key Players in Cancer-Driving Signaling PathwaysFrontiers in Pharmacology, 2021
- Recent Development in Indole Derivatives as Anticancer Agent: A Mechanistic ApproachAnti-Cancer Agents in Medicinal Chemistry, 2021
- Antitumor Agents Based on Metal–Organic FrameworksAngewandte Chemie, 2021
- Homologation: A Versatile Molecular Modification Strategy to Drug DiscoveryCurrent Topics in Medicinal Chemistry, 2019
- A new series of acetohydroxamates shows in vitro and in vivo anticancer activity against melanomaInvestigational New Drugs, 2019
- Activity of 2-Aryl-2-(3-indolyl)acetohydroxamates against Drug-Resistant Cancer CellsJournal of Medicinal Chemistry, 2015
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983